Stem Cell Research (Sep 2023)

Generation of human induced pluripotent stem cell line EURACi015-A from a patient affected by dilated cardiomyopathy carrying the Lamin A/C p.Glu161Lys mutation

  • Giada Cattelan,
  • Laura Sophie Frommelt,
  • Chiara Volani,
  • Andrea Colliva,
  • Giulio Ciucci,
  • Alessia Paldino,
  • Matteo Dal Ferro,
  • Marina Di Segni,
  • Rosamaria Silipigni,
  • Peter P. Pramstaller,
  • Marzia De Bortoli,
  • Serena Zacchigna,
  • Alessandra Rossini

Journal volume & issue
Vol. 71
p. 103172

Abstract

Read online

Dilated cardiomyopathy (DCM) is a common heart disorder caused by genetic and non-genetic etiologies, characterized by left ventricular dilatation and contractile dysfunction. Here, we created a human induced pluripotent stem cell line from peripheral blood mononuclear cells using non-integrating vectors from a patient carrying a heterozygous LMNA variant (c.481G > A, p.Glu161Lys, NM_170707.4). The obtained EURACi015-A line, showed the typical morphology of pluripotent cells, normal karyotype and exhibited pluripotency markers and a trilineage differentiation potential. This cell line can be successfully differentiated into cardiomyocytes and endothelial cells. This line represents a human in vitro model to study the genetic basis of DCM.